The Importer’s Trap in Russia — Medical Device Registration Rights and the September 2026 Deadline
You spent a year and a half and several million rubles on registering a medical device (MD) in Russia. Everything is ready, sales have started. Then something goes wrong with the distributor — poor sales, a pricing conflict, or sanction-related risks. You decide to change your partner, but they simply do not respond to requests to hand over the registration dossier. The product remains on the market, but you no longer have access to it. This is the «importer’s trap» — a situation where changing your commercial partner means losing all the results of your registration.
Since March 2025, the problem has shifted from a commercial dimension to a technological one. The new Rules for State Registration of Medical Devices (Government Resolution of the Russian Federation No. 1684 dated November 30, 2024, hereinafter GR No. 1684) have moved all interactions with Roszdravnadzor to the applicant’s unified personal account on the Gosuslugi portal (State Services). A foreign manufacturer cannot have such an account: it always belongs to a Russian representative. Whoever controls the personal account controls the registration.
How the Old Regulation Worked and What Went Wrong
Until March 1, 2025, the market operated under the rules of Government Resolution No. 1416 dated December 27, 2012. An Authorized Representative of the Manufacturer (AR) was also required back then, but the link to a specific legal entity was less rigid: there were paper originals of documents, physical test reports, and a more decentralized infrastructure for interacting with the regulator.
The standard market entry scheme looked like this: a foreign manufacturer would find a distributor with an established network, who would offer to register the device «at their own expense» in exchange for exclusivity. The manufacturer agreed — why pay yourself if the partner covers the costs? The distributor registered everything under their own name as the applicant, received test reports into their organization, and was entered into all regulatory databases.
In the event of a conflict, the picture became unpleasant: the manufacturer did not possess the original test reports, could not interact with Roszdravnadzor independently, and did not know the current state of the registration dossier. The distributor took advantage of this.
Court practice demonstrated another facet of the same issue. The responsibility for maintaining registration lay with the applicant-representative, and if they failed, the manufacturer lost the registration without any opportunity to intervene. A telling example is Case No. A40-41621/2024 (ruling of the Arbitration Court of the City of Moscow dated May 24, 2024): Russian distributor LLC «Atex Group» obtained a temporary Registration Certificate (RC) for nitrile gloves from Malaysian manufacturer Top Glove. During the subsequent mandatory examination, the company failed to address documentation deficiencies — instructions for use, information on the intended purpose of the device, and disposal procedures were all missing from the packaging. Roszdravnadzor revoked the registration. Top Glove, whose product effectively lost the Russian market, was not a party to the dispute. The entire process ran through the distributor, and the manufacturer had no direct leverage.
There was no malicious intent in this case — just negligence in handling documentation. But if the distributor had deliberately blocked access to the dossier during a conflict with the manufacturer, the outcome would have been exactly the same.
What Has Changed Since March 2025
GR No. 1684 entered into force on March 1, 2025, and replaced GR No. 1416. The document is valid until December 31, 2026 — transitional regulation for the period of the system’s digital restructuring. The rules that replace it will very likely retain the same logic, but on a permanent basis.
Now, what exactly has changed. The applicant submits all documents through the unified personal account in the ESIA (Gosuslugi) and signs them with an Enhanced Qualified Electronic Signature (EQES). Paper RC blanks have been abolished: the fact of registration is now confirmed by a registry entry in the state register of medical devices. Registration has become indefinite (Clause 25 of GR No. 1684).
Pursuant to Clause 4 of GR No. 1684, an AR is a legal entity or an individual entrepreneur residing in the Russian Federation, authorized by the manufacturer to represent its interests in matters of MD circulation, including conformity assessment and state registration. It is the AR — or the manufacturer themselves, if they are a Russian entity — who acts as the «applicant». A foreign manufacturer without an AR cannot participate in registration procedures at all (Clause 29 of GR No. 1684).
How the mechanics have changed:
| Parameter | Before (GR No. 1416) | Now (GR No. 1684) |
|---|---|---|
| Format of registration | Paper RC blank | Registry entry (indefinite) |
| Interaction with the regulator | Hybrid (paper and electronic) | Exclusively via Personal Account (ESIA + EQES) |
| Changing the AR | Application-based procedure | Application-based, but strictly via the current applicant’s account |
| Deadline for updating AR details | Not regulated | September 1, 2026 (Clause 29 of GR No. 1684) |
| Consequence of lacking an active AR | Administrative risks | Suspension, followed by cancellation (from September 1, 2026) |
Clause 137(e) of GR No. 1684 introduces a separate enforcement mechanism. If the manufacturer fails to update the document confirming the AR’s authority in the dossier within 90 business days of its expiration, Roszdravnadzor suspends the registration and subsequently cancels it. This clause enters into force on September 1, 2026 — precisely when manufacturers with inactive or hostile ARs will begin facing hard deadlines.
A Closed Digital Loop
Changing an AR under GR No. 1684 is possible without a full examination and takes 18 business days (Sub-clauses 111(d), 112–113). It sounds straightforward. However, the application to change the representative must be submitted through the personal account of the current applicant — through the account of the active AR.
In the event of a conflict with the distributor, this creates a deadlock: to appoint a new representative, the old one must initiate the procedure through their own account. Without a clearly defined penalty mechanism in the contract, achieving this in practice is virtually impossible.
Three Models of Working with an AR
The choice of market presence model largely determines the level of registration protection under any scenario involving a commercial partner.
Model A. Independent Professional AR. A regulatory consultant, legal firm, or CRO performs the AR’s functions for a fixed fee. They have no commercial interest in selling the device, and a conflict with the distributor does not affect the registration in any way. Maintaining an active registration costs from 300,000 to 1,500,000 RUB per year, depending on the product portfolio and risk class (market estimate, not established by regulatory instruments). Changes and responses to Roszdravnadzor inquiries are billed separately. This is the most secure model of the three.
Model B. Own Russian Subsidiary (LLC). Full control: the applicant’s personal account belongs to the manufacturer’s own structure. Changing any distributor leaves the registration untouched. The downside: the cost of maintaining a legal entity and geopolitical risks if it ever needs to be wound down.
Model C. Distributor as AR. The most widespread model and, simultaneously, the most risky. Acceptable only with the correct contractual architecture — otherwise it is a direct path into the trap.
What to Do
Conduct an audit of current contracts. Check three things: who owns the original test reports (was the manufacturer or the AR the party to the contract with the laboratories?); does the contract contain an obligation for the AR to hand over the dossier upon request; is the procedure for changing the AR specified with concrete deadlines and financial penalties? If none of these points are present, you are in the risk zone.
Verify the AR’s details in the state registry. Open the MD registry on the Roszdravnadzor website (roszdravnadzor.gov.ru), find your products, and confirm that the AR data matches the active contract and that the authority document has not expired. The update deadline under Clause 29 of GR No. 1684 is September 1, 2026. After this date, missing up-to-date information will trigger suspension, followed by cancellation.
Separate commercial and regulatory contracts. If the distributor also acts as the AR, conclude two separate agreements: a distribution agreement for commercial terms, and an AR agreement for regulatory obligations (managing the dossier, interacting with Roszdravnadzor, accessing application status information, handing over documents). Terminating one contract must not automatically terminate the other.
Include three mandatory blocks in the AR agreement. The first concerns rights to the registration dossier: all test reports, technical documentation, and correspondence with the regulator remain the manufacturer’s property; the AR holds them as an agent and is obliged to hand them over upon request. The second covers digital access: the AR regularly reports on registration statuses, does not change the account credentials without notice, and maintains an active EQES. The third governs the change procedure: upon termination of the agreement, the AR is obliged to submit an update application through the personal account within [N] business days, with a daily penalty accruing for each day of delay. Without a financial enforcement mechanism, this obligation will remain on paper only.
Limit the Power of Attorney to a maximum of one year. Specify only powers related to registration and quality matters. Prohibit sub-authorization to third parties. Notarize and apostille (for countries party to the Hague Convention). A short-term PoA compels the AR to maintain a working relationship in order to secure its renewal — and that is precisely how it functions as insurance.
September 1, 2026 is not an abstract date. This is the moment when the absence of up-to-date AR information will begin translating into concrete regulatory consequences. The 2026 transitional period is the last opportunity to put contractual relationships in order before reaching emergency mode. In parallel, it is worth monitoring the development of the permanent regulation that will replace GR No. 1684 after December 31, 2026 — which, judging by the current trend, will preserve the same digital logic.
Regulatory Framework:
1. Government Resolution of the Russian Federation No. 1684 dated November 30, 2024 «On Approval of the Rules for State Registration of Medical Devices» (as amended on October 27, 2025)
2. Government Resolution of the Russian Federation No. 1206 dated August 13, 2025 (amending GR No. 1684, postponing the deadline for updating AR details to September 1, 2026)
3. Government Resolution of the Russian Federation No. 1416 dated December 27, 2012 (invalid since March 1, 2025)
4. Federal Law No. 323-FZ dated November 21, 2011 «On the Basics of Health Protection of Citizens in the Russian Federation» (Article 38)
5. Ruling of the Arbitration Court of the City of Moscow dated May 24, 2024, Case No. A40-41621/2024